Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

IARC 50th Anniversary Conference /
Germline mutations influence risk and recovery throughout life

7th - 10th Jun 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.07.16
Views: 1749

Dr Stephen Chanock - United States National Cancer Institute, Bethesda, USA

Dr Chanock speaks with ecancertv at IARC 2016 about increased risk of cancer passed down through heritable genetic mutations.

Weighing genomics against the influence of environmental factors, Dr Chanock discusses a patients' polygenic risk score.

Accurate scoring and stratification may not only reflect patient susceptibility to disease, but also predict which treatments would be best tolerated and overall wellbeing.



Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation